Evaluating Safety and Clinical Activity of Front-line Treatment with Cadonilimab plus Chemotherapy in Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring STK11 Genetic Aberration: A Protocol of Phase II Study
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:1525-7304
-
Container-title:Clinical Lung Cancer
-
language:en
-
Short-container-title:Clinical Lung Cancer
Author:
Jiang HuixinORCID,
Sun Ni,
Li Ru,
Guan Wenhui,
Zhu Yue,
Xie Zhanhong,
Xie Xiaohong,
Liu Ming,
Lin Xinqing,
Zhou ChengzhiORCID